CSIMarket

Outpacing Competitors with Impressive Financial Performance

Intuitive Surgical Inc delivered first quarter of 2024 operating profit of $469.4 million


Published / Modified Apr 20 2024
Goran Soko / CSIMarket.com


Intuitive Surgical Inc, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, recently announced its financial results for the quarter ended March 31, 2024.
The company reported significant growth in both income and revenue, outperforming its peers in the Medical Equipment & Supplies sector.

During this period, Intuitive Surgical Inc experienced a 51% increase in income, with earnings per share reaching $1.51.
Additionally, the company witnessed an 11.449% boost in revenue, amounting to $1.89 billion.
This positive performance in revenue growth is particularly noteworthy, as many of its peers in the Medical Equipment & Supplies sector saw a contraction in their top-line numbers.

Comparing these figures to the previous reporting season, profits fell by -11.37% from $1.70 per share, and revenue decreased by -1.96% from $1.93 billion.
However, in the current financial quarter, net earnings reached $547.400 million, an increase of 51.72% from the same period a year ago.
Intuitive Surgical Inc also highlighted its improving profit margins, with a net margin of 28.96% and an operating margin of 24.83% in the financial first quarter of 2024.

One noticeable aspect of the company's financials is the increase in
inventories and supplies, which reached $1,299.3 million.
This is higher than the preceding quarter and the corresponding quarter a year ago.
Conversely, operating earnings improved by just 21.1% to $469.4 million.
Additionally, accounts receivable declined to $1,127.9 million compared to the previous quarter, although it remains higher than the same period a year ago.

In April 2024, Intuitive Surgical Inc made an exciting announcement regarding the FDA clearance of their fifth-generation robotic system, da Vinci 5.
As a global leader in robotic-assisted surgery, this development showcases the company's continuous innovation and expertise in the field.
The da Vinci 5 system represents years of research, innovation, and insights gained from millions of successful robotic procedures using previous generations of the da Vinci system.
This milestone further solidifies Intuitive Surgical Inc's position as a frontrunner in surgical robotics.

Looking at the company's stock performance, it has increased 40.34% over the past year, contributing to a year-to-date performance of 14.01%. Additionally, the stock is trending higher and is only 6.4% shy of its 52-week high, demonstrating positive market sentiment.

Overall, Intuitive Surgical Inc's financial results for the first quarter of 2024 showcase strong growth in income and revenue.
The company's ability to outperform its peers in the Medical Equipment & Supplies sector, along with its FDA clearance of the da Vinci 5 robotic system, positions it as an industry leader in minimally invasive care and surgical robotics.
With a promising stock performance, Intuitive Surgical Inc is poised for continued success in the future.



Intuitive Surgical Inc's Revenue per Employee

Intuitive Surgical Inc's Operating Margin



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com